TRILC.E — Turk Ilac ve Serum Sanayi AS Income Statement
0.000.00%
- TRY4.11bn
- TRY5.49bn
- TRY1.91bn
- 43
- 26
- 81
- 46
Annual income statement for Turk Ilac ve Serum Sanayi AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 152 | 200 | 673 | 1,637 | 1,913 |
Cost of Revenue | |||||
Gross Profit | 70 | 99.1 | 120 | 354 | 429 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 107 | 134 | 597 | 1,463 | 1,655 |
Operating Profit | 44.7 | 66 | 75.8 | 174 | 259 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.5 | 40.3 | 46.9 | -9.67 | 82.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 13.5 | 33.3 | 37.1 | -81.7 | 106 |
Net Income Before Extraordinary Items | |||||
Net Income | 13.5 | 33.3 | 37.1 | -81.7 | 106 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 13.5 | 33.3 | 37.1 | -81.7 | 106 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.093 | 0.234 | 0.227 | -0.504 | 0.653 |
Dividends per Share |